The Mathematician Versus the Malignancy
Elie Dolgin • May 7, 2014
Patients have long received cancer treatments at the maximum tolerated dose on a regular schedule. Could a more sophisticated approach save lives?
Elie Dolgin meets one mathematical biologist whose theories are now being tested in the clinic to see if they can improve the efficacy of today's anticancer arsenal.
Continue reading at Nature Medicine.
Zebras and giraffes offer one another protection without food competition.
Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with fewer side effects.